Novonesis AS

Major Shareholding Notification • Nov 20, 2013

November 20, 2013

In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, has decreased its holding of B shares in Novozymes to 7.45%, previously reported at 7.56% (a decrease of 0.11%).

Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds B shares in Novozymes A/S to a total of 24,196,308 shares of a nominal value of DKK 48,392,616, equivalent to 7.45% of Novozymes A/S' share capital and 2.99% of the voting rights. The announcement is a result of Baillie Gifford Overseas Limited, a wholly owned subsidiary of Baillie Gifford & Co, decreasing its holding of B shares in Novozymes A/S to a total of 15,986,454 B shares of a nominal value of DKK 31,972,908, equivalent to 4.92% of Novozymes share capital.

Contact information

.

Thomas Bomhoff (DK) +45 3077 1226 tsbm@novozymes.com Klaus Sindahl (DK) +45 5363 0134 ksdh@novozymes.com Martin Riise (USA) +1 919 649 2565 mrsn@novozymes.com Press and media: Rene Tronborg (DK) +45 3077 2274 retr@novozymes.com Frederik Bjoerndal (Europe) +45 3077 0236 tfbh@novozymes.com Paige Donnelly (USA) +1 919 218 4501 pagd@novozymes.com Meng Lian (China) +86 136 9923 1164 mexl@novozymes.com Henrique Pellini (Brazil) +55 41 9288 0282 hqp@novozymes.com Poonam Kapila (India) +91 991 082 2339 poka@novozymes.com	Investor Relations:

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Company announcement No. 25, 2013 Page 1 of 1

Krogshoejvej 36 2880 Bagsvaerd Denmark

Telephone: +45 4446 0000 Email: novozymesIR@novozymes.com Internet: www.novozymes.com